We are live on ! Find out more
HQY icon

HealthEquity

326 hedge funds and large institutions have $4.48B invested in HealthEquity in 2019 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 118 increasing their positions, 105 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 44

26% more capital invested

Capital invested by funds: $3.55B → $4.48B (+$935M)

12% more repeat investments, than reductions

Existing positions increased: 118 | Existing positions reduced: 105

5% more funds holding

Funds holding: 310326 (+16)

1.35% more ownership

Funds ownership: 96.31%97.66% (+1.3%)

34% less call options, than puts

Call options by funds: $14.6M | Put options by funds: $22M

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
326
Holders Change
+16
Holders Change %
+5.16%
% of All Funds
7.05%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
61
Increased
118
Reduced
105
Closed
44
Calls
$14.6M
Puts
$22M
Net Calls
-$7.38M
Net Calls Change
+$7.11M
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$482M +$6.3M +89,576 +1%
BlackRock
2
BlackRock
New York
$476M -$23.6M -335,763 -5%
Vanguard Group
3
Vanguard Group
Pennsylvania
$408M +$5.17M +73,538 +1%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$212M -$31.5M -448,324 -14%
WA
5
Wasatch Advisors
Utah
$151M +$26.5M +376,461 +23%
Invesco
6
Invesco
Georgia
$139M -$4.4M -62,625 -3%
Janus Henderson Group
7
Janus Henderson Group
United Kingdom
$134M -$45.4M -645,184 -26%
JSP
8
Jackson Square Partners
California
$129M +$122M +1,737,284 New
State Street
9
State Street
Massachusetts
$125M +$930K +13,222 +0.8%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$86.2M +$12.3M +174,507 +18%
Wells Fargo
11
Wells Fargo
California
$71.2M +$19.6M +279,115 +41%
BAMCO Inc
12
BAMCO Inc
New York
$70.6M +$21.1K +300 +0%
FAM
13
Fred Alger Management
New York
$66.4M -$873K -12,414 -1%
Northern Trust
14
Northern Trust
Illinois
$64.6M +$996K +14,168 +2%
Ameriprise
15
Ameriprise
Minnesota
$63.2M +$18.9M +268,841 +46%
JP Morgan Chase
16
JP Morgan Chase
New York
$60.3M -$3.92M -55,785 -6%
CS
17
Credit Suisse
Switzerland
$56.2M +$7.42M +105,588 +16%
Victory Capital Management
18
Victory Capital Management
Texas
$52.2M -$117K -1,658 -0.2%
Goldman Sachs
19
Goldman Sachs
New York
$52.2M +$3.47M +49,301 +8%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$49.5M +$2.96M +42,095 +7%
Renaissance Technologies
21
Renaissance Technologies
New York
$48.6M +$105K +1,500 +0.2%
ACH
22
ArrowMark Colorado Holdings
Colorado
$47M +$2.51M +35,771 +6%
Artisan Partners
23
Artisan Partners
Wisconsin
$46.9M +$1.69M +24,056 +4%
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$43M -$3.97M -56,483 -9%
EAM
25
Eagle Asset Management
Florida
$40.9M -$31.4M -447,272 -45%

HQY Hedge Fund Activity: Q1 2019 in Review

326 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in HealthEquity (HQY) for Q1 2019, worth a combined $4.48B — up 26% from $3.55B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new HQY positions and 44 closed out — a net gain of 17 holders — while 118 added to existing stakes and 105 trimmed.

The largest buyer was Jackson Square Partners, opening a new position worth an estimated $122M. The largest seller was Janus Henderson Group, cutting an estimated $45.4M.

  • 326 institutional investors held HealthEquity (HQY) as of Q1 2019, up from 310 in Q4 2018.
  • Funds reported $4.48B of HealthEquity stock for Q1 2019, up 26% quarter-over-quarter.
  • 61 funds opened new HealthEquity positions in Q1 2019 and 44 closed out, a net change of +17 holders.
  • The largest HealthEquity buyer in Q1 2019 was Jackson Square Partners, an estimated $122M added.
  • The largest HealthEquity seller in Q1 2019 was Janus Henderson Group, an estimated $45.4M sold.

Based on aggregated 13F filings for Q1 2019.